All
Results: 34489-34500 of 60507

Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

Kolibri Global Energy Inc. Finishes Drilling Its First Three 1.5 Mile Lateral Wells Under Budget and Quicker Than Forecasted

Lockdown generation consigned to the ‘scrapheap’ will get life-changing support into work, vows Minister






